IFNA2 and neoplasm: Instead, patient #5 presented a mTDLN with a low HLA-I tumor expression but a high percentage of CD4+ T cells (44%) and a high number of CD20+ nests in the peritumoral area (Table 1) before treatment with interferon alpha-2b.